Dawn Carter Bir
CIK 1688712 · Interim President and CEO · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
30
Lifetime Open-Market Net
-$26.15M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GERN | Interim President and CEO | — | $1.15 | — | $0 | 9 | 2026-05-26 |
| SLNO | Director | 0 | $53.01 | $0 | $0 | 3 | 2026-05-18 |
| CASSAVA SCIENCES INC (SAVA) Delisted | Director | — | $2.34 | — | $0 | 1 | 2025-10-22 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | Chief Commercial Officer | 0 | $172.36 | $0 | -$26.15M | 17 | 2023-09-26 |
Recent Filings · Page 2 of 3
30 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-10 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | +4,125 | $0 | EDGAR |
| 2023-06-02 | GERN | Grant (A) | — | $0 | EDGAR |
| 2023-05-17 | REATA PHARMACEUTICALS INC (RETA) Delisted | Sell (S) | −1,311 | -$109.8K | EDGAR |
| 2023-03-15 | REATA PHARMACEUTICALS INC (RETA) Delisted | Sell (S) | −9,317 | -$808.4K | EDGAR |
| 2023-03-08 | REATA PHARMACEUTICALS INC (RETA) Delisted | Mixed | −6,996 | -$8.50M | EDGAR |
| 2023-03-06 | REATA PHARMACEUTICALS INC (RETA) Delisted | Sell (S) | −2,166 | -$191.1K | EDGAR |
| 2023-01-04 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | +15,675 | $0 | EDGAR |
| 2022-05-11 | GERN | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
| 2021-05-13 | GERN | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.